WFDC2 suppresses prostate cancer metastasis by modulating EGFR signaling inactivation
- PMID: 32678075
- PMCID: PMC7366654
- DOI: 10.1038/s41419-020-02752-y
WFDC2 suppresses prostate cancer metastasis by modulating EGFR signaling inactivation
Abstract
WAP four-disulfide core domain 2 (WFDC2) is a small secretory protein that has been widely studied in ovarian cancer. It has been proven that WFDC2 promotes proliferation and metastasis in ovarian cancer, and serves as a diagnostic biomarker. However, the specific function of WFDC2 in prostate cancer has not been reported. Here, we first screened the diagnostic marker and favorable prognostic factor WFDC2 in prostate cancer by bioinformatics. WFDC2 expression was negatively correlated with Gleason score and metastasis in prostate cancer. Then, we revealed that overexpression of WFDC2, and addition of recombinant protein HE4 can significantly inhibit prostate cancer metastasis in vivo and in vitro. By co-immunoprecipitation and co-localization assays, we proved that WFDC2 binds to the extracellular domain of epidermal growth factor receptor (EGFR). Immunoblot showed that WFDC2 overexpression and recombinant protein HE4 addition inactivated the EGFR/AKT/GSK3B/Snail signaling pathway, and then restrained the progression of epithelial-mesenchymal transition. In conclusion, our study identified that the tumor suppressor WFDC2 can suppress prostate cancer metastasis by inactivating EGFR signaling.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
A bioinformatic analysis of WFDC2 (HE4) expression in high grade serous ovarian cancer reveals tumor-specific changes in metabolic and extracellular matrix gene expression.Med Oncol. 2022 May 15;39(5):71. doi: 10.1007/s12032-022-01665-4. Med Oncol. 2022. PMID: 35568777 Free PMC article.
-
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes.Sci Rep. 2020 May 22;10(1):8558. doi: 10.1038/s41598-020-65353-x. Sci Rep. 2020. PMID: 32444701 Free PMC article.
-
WFDC2 Promotes Spasmolytic Polypeptide-Expressing Metaplasia Through the Up-Regulation of IL33 in Response to Injury.Gastroenterology. 2021 Sep;161(3):953-967.e15. doi: 10.1053/j.gastro.2021.05.058. Epub 2021 Jun 8. Gastroenterology. 2021. PMID: 34116028 Free PMC article.
-
WAP four-disulfide core domain protein 2 mediates the proliferation of human ovarian cancer cells through the regulation of growth- and apoptosis-associated genes.Oncol Rep. 2013 Jan;29(1):288-96. doi: 10.3892/or.2012.2114. Epub 2012 Oct 31. Oncol Rep. 2013. PMID: 23129262
-
Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer?Curr Drug Targets. 2020;21(10):1026-1033. doi: 10.2174/1389450121666200425211732. Curr Drug Targets. 2020. PMID: 32334501 Review.
Cited by
-
Multimodal data integration for predicting progression risk in castration-resistant prostate cancer using deep learning: a multicenter retrospective study.Front Oncol. 2024 Mar 14;14:1287995. doi: 10.3389/fonc.2024.1287995. eCollection 2024. Front Oncol. 2024. PMID: 38549937 Free PMC article.
-
HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target.Cell Death Dis. 2021 Feb 1;12(2):137. doi: 10.1038/s41419-021-03417-0. Cell Death Dis. 2021. PMID: 33542203 Free PMC article.
-
Plasma proteomic signature of risk and prognosis of frailty in the UK Biobank.Geroscience. 2024 Nov 13. doi: 10.1007/s11357-024-01415-6. Online ahead of print. Geroscience. 2024. PMID: 39535692
-
Ubiquitin specific peptidases and prostate cancer.PeerJ. 2023 Feb 16;11:e14799. doi: 10.7717/peerj.14799. eCollection 2023. PeerJ. 2023. PMID: 36811009 Free PMC article. Review.
-
Versatile whey acidic protein four-disulfide core domain proteins: biology and role in diseases.Front Cell Dev Biol. 2024 Sep 4;12:1459129. doi: 10.3389/fcell.2024.1459129. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39296934 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
